Targeted next generation sequencing as a tool for precision medicine.
Bmc Medical Genomics
Gulilat, Markus M; Lamb, Tyler T; Teft, Wendy A WA; Wang, Jian J; Dron, Jacqueline S JS; Robinson, John F JF; Tirona, Rommel G RG; Hegele, Robert A RA; Kim, Richard B RB; Schwarz, Ute I UI
Publication Date: 2019-06-03
Variant appearance in text: FMO2: F69Y; rs28745274
Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response.
Oncogene
Nickerson, M L ML; Witte, N N; Im, K M KM; Turan, S S; Owens, C C; Misner, K K; Tsang, S X SX; Cai, Z Z; Wu, S S; Dean, M M; Costello, J C JC; Theodorescu, D D
Publication Date: 2017-01-05
Variant appearance in text: FMO2: F69Y; rs28745274
The potentially deleterious functional variant flavin-containing monooxygenase 2*1 is at high frequency throughout sub-Saharan Africa.
Pharmacogenetics And Genomics
Veeramah, Krishna R KR; Thomas, Mark G MG; Weale, Michael E ME; Zeitlyn, David D; Tarekegn, Ayele A; Bekele, Endashaw E; Mendell, Nancy R NR; Shephard, Elizabeth A EA; Bradman, Neil N; Phillips, Ian R IR